Patient perceived value of teleophthalmology in an urban, low income US population with diabetes


Autoři: Rajeev S. Ramchandran aff001;  Sule Yilmaz aff002;  Evelyn Greaux aff003;  Ann Dozier aff004
Působiště autorů: Department of Ophthalmology, Flaum Eye Institute, University of Rochester Medical Center, Rochester, NY, United States of America aff001;  Department of Human Development and Counseling, Warner School of Education, University of Rochester, Rochester, NY, United States of America aff002;  Department of Biology, College of Arts and Sciences, University of Rochester, Rochester, NY, United States of America aff003;  Department of Public Health Sciences, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States of America aff004
Vyšlo v časopise: PLoS ONE 15(1)
Kategorie: Research Article
prolekare.web.journal.doi_sk: 10.1371/journal.pone.0225300

Souhrn

Dilated eye exams are the standard of care to detect advancing, vision threatening, but often asymptomatic retinopathy in a timely fashion, allowing for vision preserving treatments. Annual exam rates are suboptimal, especially in underserved populations. Although teleophthalmology programs tremendously improve annual exam rates in low income/under resourced settings, widespread adoption is limited. Using a mixed methods approach, three focus groups and individual interviews were conducted for patients with type 2 diabetes (N = 23) who had a teleophthalmology exam or a dilated eye exam. A survey and discussion assessed patients’ perspectives and value of teleophthalmology, including willingness to pay (WTP). Financial, transportation, and motivational barriers to obtaining an annual dilated eye exam were identified. Patients greatly valued having primary care (PC) based teleophthalmology for its convenience and ability to detect disease to allow for timely treatment and would recommend such a service. Although their WTP was at least the amount of their usual copay, cost was universally cited as a concern. Having a conveniently offered PC based teleophthalmology exam was valued. Educating patients on the value and costs of having such exams may be helpful to encourage informed discussions on eye care, especially in low income, underserved populations. Our study is among the few to provide insight on the value and perceptions of teleophthalmology in US low income, urban minority populations needed to help increase uptake of this innovation. Using surveys followed by facilitated discussion allowed for richer and more varied responses.

Klíčová slova:

Diabetes mellitus – Diabetic retinopathy – Eye diseases – Eyes – Insurance – Medical doctors – Primary care – Vision


Zdroje

1. Facts About Diabetic Eye Disease | National Eye Institute [Internet]. National Eye Institute. 2015 [cited 2018 Aug 21]. Available from: https://nei.nih.gov/health/diabetic/retinopathy

2. Singer DE, Nathan DM, Fogel HA, Schachat AP. Screening for diabetic retinopathy. Ann Intern Med. 1992;116(8):660–71. doi: 10.7326/0003-4819-116-8-660 1546868

3. Network DRCR. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193–1203. doi: 10.1056/NEJMoa1414264 25692915

4. Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Ma’an AN, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology. 2006;113(10):1695–1705. doi: 10.1016/j.ophtha.2006.05.064 17011951

5. Mukamel BD, Bresnick HG, Wang Q, Dickey FC. Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol. 1999;6(1):61–72. doi: 10.1076/opep.6.1.61.1563 10384685

6. Lee PP, Feldman ZW, Ostermann J, Brown DS, Sloan FA. Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. Ophthalmology. 2003;110(10):1952–9. doi: 10.1016/S0161-6420(03)00817-0 14522771

7. Keenum Z, McGwin G, Witherspoon CD, Haller JA, Clark ME, Owsley C. Patients’ Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors Associated With Follow-up Eye Care Use. JAMA Ophthalmol. 2016;134(11):1221–8. doi: 10.1001/jamaophthalmol.2016.3081 27632231

8. Daskivich LP, Vasquez C, Martinez C, Tseng C-H, Mangione CM. Implementation and Evaluation of a Large-Scale Teleretinal Diabetic Retinopathy Screening Program in the Los Angeles County Department of Health Services. JAMA Intern Med. 2017;177(5):642–9. doi: 10.1001/jamainternmed.2017.0204 28346590

9. Jani PD, Forbes L, Choudhury A, Preisser JS, Viera AJ, Garg S. Evaluation of Diabetic Retinal Screening and Factors for Ophthalmology Referral in a Telemedicine Network. JAMA Ophthalmol. 2017;135(7):706–14. doi: 10.1001/jamaophthalmol.2017.1150 28520833

10. Cavallerano JD, Bursell SE, Aiello LM. Telemedicine and Eye Examinations for Diabetic Retinopathy A Time to Maximize Real-World Outcomes. Health (N Y). 2011;17(10):814–837.

11. Silva PS, Aiello LP. Telemedicine and eye examinations for diabetic retinopathy: a time to maximize real-world outcomes. JAMA Ophthalmol. 2015;133(5):525–526. doi: 10.1001/jamaophthalmol.2015.0333 25742322

12. Anderson RM, Robins LS. How Do We Know? Reflections on qualitative research in diabetes. Diabetes Care. 1998;21(9):1387–8. doi: 10.2337/diacare.21.9.1387 9727880

13. Livingston P.M., McCarty C.A., Wood C.A., Harper A.C., Keeff J.E., Taylor H.R. Use of focus groups to identify health promotion strategies for the early detection of diabetic retinopathy. Aust N Z J Public Health. 2008;22(2):220–2.

14. Dawn AG, McGwin G, Lee PP. Patient Expectations Regarding Eye Care: Development and Results of the Eye Care Expectations Survey (ECES). Arch Ophthalmol. 2005;123(4):534–41. doi: 10.1001/archopht.123.4.534 15824228

15. Greenhalgh T, Helman C, Chowdhury AM. Health beliefs and folk models of diabetes in British Bangladeshis: a qualitative study. BMJ. 1998;316(7136):978–83. doi: 10.1136/bmj.316.7136.978 9550958

16. Hartnett ME, Key IJ, Loyacano NM, Horswell RL, DeSalvo KB. Perceived Barriers to Diabetic Eye Care: Qualitative Study of Patients and Physicians. Arch Ophthalmol. 2005;123(3):387–91. doi: 10.1001/archopht.123.3.387 15767483

17. Coyne KS. The impact of diabetic retinopathy: perspectives from patient focus groups. Fam Pract. 2004;21(4):447–53. doi: 10.1093/fampra/cmh417 15249536

18. Owsley C, McGwin G, Scilley K, Girkin CA, Phillips JM, Searcey K. Perceived Barriers to Care and Attitudes about Vision and Eye Care: Focus Groups with Older African Americans and Eye Care Providers. Invest Ophthalmol Vis Sci. 2006;47(7):2797–802. doi: 10.1167/iovs.06-0107 16799016

19. Ellish NJ, Royak-Schaler R, Passmore SR, Higginbotham EJ. Knowledge, attitudes, and beliefs about dilated eye examinations among African-Americans. Invest Ophthalmol Vis Sci. 2007;48(5):1989–1994. doi: 10.1167/iovs.06-0934 17460251

20. Liu Y, Zupan NJ, Shiyanbola OO, Swearingen R, Carlson JN, Jacobson NA, et al. Factors influencing patient adherence with diabetic eye screening in rural communities: A qualitative study. PloS One. 2018;13(11):e0206742. doi: 10.1371/journal.pone.0206742 30388172

21. Rotvold G-H, Knarvik U, Johansen MA, Fossen K. Telemedicine screening for diabetic retinopathy: staff and patient satisfaction. J Telemed Telecare. 2003;9(2):109–13. doi: 10.1258/135763303321327984 12699582

22. Kurji K, Kiage D, Rudnisky CJ, Damji KF. Improving Diabetic Retinopathy Screening in Africa: Patient Satisfaction with Teleophthalmology Versus Ophthalmologist-Based Screening. Middle East Afr J Ophthalmol. 2013;20(1):56–60. doi: 10.4103/0974-9233.106388 23580853

23. Kumari Rani P, Raman R, Manikandan M, Mahajan S, Paul PG, Sharma T. Patient satisfaction with tele-ophthalmology versus ophthalmologist-based screening in diabetic retinopathy. J Telemed Telecare. 2006;12(3):159–60. doi: 10.1258/135763306776738639 16638238

24. Paul PG, Raman R, Rani PK, Deshmukh H, Sharma T. Patient satisfaction levels during teleophthalmology consultation in rural South India. Telemed J E Health. 2006;12(5):571–578. doi: 10.1089/tmj.2006.12.571 17042711

25. Surendran TS, Raman R. Teleophthalmology in diabetic retinopathy. J Diabetes Sci Technol. 2014;8(2):262–266. doi: 10.1177/1932296814522806 24876576

26. Luzio S, Hatcher S, Zahlmann G, Mazik L, Morgan M, Liesenfeld B, et al. Feasibility of using the TOSCA telescreening procedures for diabetic retinopathy. Diabet Med. 2004;21(10):1121–1128. doi: 10.1111/j.1464-5491.2004.01305.x 15384960

27. Wu Y, Wei Z, Yao H, Zhao Z, Ngoh LH, Deng RH, et al. TeleOph: A Secure Real-Time Teleophthalmology System. IEEE Trans Inf Technol Biomed. 2010;14(5):1259–66. doi: 10.1109/TITB.2010.2058124 20667812

28. Hipwell AE, Sturt J, Lindenmeyer A, Stratton I, Gadsby R, O’Hare P, et al. Attitudes, access and anguish: a qualitative interview study of staff and patients’ experiences of diabetic retinopathy screening. BMJ Open. 2014;4(12):e005498. doi: 10.1136/bmjopen-2014-005498 25510885

29. Ogunyemi O, George S, Patty L, Teklehaimanot S, Baker R. Teleretinal screening for diabetic retinopathy in six Los Angeles urban safety-net clinics: final study results. In: AMIA Annual Symposium Proceedings. American Medical Informatics Association. 2013;2013:1082.

30. Liu Y, Zupan NJ, Swearingen R, Jacobson N, Carlson JN, Mahoney JE, et al. Identification of barriers, facilitators and system-based implementation strategies to increase teleophthalmology use for diabetic eye screening in a rural US primary care clinic: a qualitative study. BMJ Open. 2019;9(2):e022594. doi: 10.1136/bmjopen-2018-022594 30782868

31. Valikodath NG, Leveque TK, Wang SY, Lee PP, Newman-Casey PA, Hansen SO, et al. Patient attitudes toward telemedicine for diabetic retinopathy. Telemed E-Health. 2017;23(3):205–212.

32. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357. doi: 10.1093/intqhc/mzm042 17872937

33. National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS Questionnaire [Internet]. 2016 [cited 2016 Jul 9]. Available from: https://www.cdc.gov/brfss/questionnaires/index.htm

34. Moss SE, Klein R, Klein BEK. Factors Associated With Having Eye Examinations in Persons With Diabetes. Arch Fam Med. 1995;4(6):529. doi: 10.1001/archfami.4.6.529 7773429

35. Paz SH, Varma R, Klein R, Wu J, Azen SP. Noncompliance with Vision Care Guidelines in Latinos with Type 2 Diabetes Mellitus: The Los Angeles Latino Eye Study. Ophthalmology. 2006;113(8):1372–7. doi: 10.1016/j.ophtha.2006.04.018 16769120

36. Liu Y, Swearingen R. Diabetic Eye Screening: Knowledge and Perspectives from Providers and Patients. Curr Diab Rep. 2017;17(10):94. doi: 10.1007/s11892-017-0911-2 28856510

37. Walker EA, Basch CE, Howard CJ, Zybert PA, Kromholz WN, Shamoon H. Incentives and barriers to retinopathy screening among African-Americans with diabetes. J Diabetes Complications. 1997;11(5):298–306. doi: 10.1016/s1056-8727(96)00121-3 9424171

38. Snoswell C, Smith AC, Scuffham PA, Whitty JA. Economic evaluation strategies in telehealth: Obtaining a more holistic valuation of telehealth interventions. J Telemed Telecare. 2017;23(9):792–796. doi: 10.1177/1357633X16671407 27789615

39. Sharafeldin N, Kawaguchi A, Sundaram A, et al. Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults. Br J Ophthalmol (England). 2018;102(11):1485–1491

40. Mathieson et al. Access to Digital Communication Technology and Perceptions of Telemedicine for Patient Education among American Indian Patients with Diabetes. J Health Care Poor Underserved. 2017;28(4):1522–1536. doi: 10.1353/hpu.2017.0131 29176112

41. Snoswell CL, et al. Direct-to-consumer mobile teledermoscopy for skin cancer screening: Preliminary results demonstrating willingness-to-pay in Australia. J Telemed Telecare. 2018;24(10):683–689. doi: 10.1177/1357633X18799582 30343653

42. Qureshi, Abrar A., Brandling-Bennett Heather A, Eve Wittenberg, Chen Suephy C., Sober Arthur J., et al. Willingness-to-Pay Stated Preferences for Telemedicine versus in-Person Visits in Patients with a History of Psoriasis or Melanoma. Telemedicine Journal and E-Health, 2006;12(6):639–643. doi: 10.1089/tmj.2006.12.639 17250485

43. Olsen JA, Smith RD. Theory versus practice: a review of ‘willingness-to-pay’ in health and health care. Health Econ. 2001;10(1):39–52. doi: 10.1002/1099-1050(200101)10:1<39::aid-hec563>3.0.co;2-e 11180568

44. Liu Y, Torres Diaz A, Benkert R. Scaling Up Teleophthalmology for Diabetic Eye Screening: Opportunities for Widespread Implementation in the USA. Curr Diab Rep. 2019 Aug 2;19(9):74. doi: 10.1007/s11892-019-1187-5 31375932

45. Labiris G, Panagiotopoulou EK, Kozobolis VP. A systematic review of teleophthalmological studies in Europe. Int J Ophthalmol. 2018;11(2):314–325. doi: 10.18240/ijo.2018.02.22 29487825

46. Rathi S, Tsui E, Mehta N, Zahid S, Schuman JS. The Current State of Teleophthalmology in the United States. Ophthalmology. 2017;124(12):1729–1734. doi: 10.1016/j.ophtha.2017.05.026 28647202


Článok vyšiel v časopise

PLOS One


2020 Číslo 1

Najčítanejšie v tomto čísle

Tejto téme sa ďalej venujú…


Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Význam nutraceutik u kardiovaskulárních onemocnění
nový kurz
Autori:

Faktory ovlivňující léčbu levotyroxinem

Kurz originály vs. generika

Autori: MUDr. Petr Výborný, CSc., FEBO

Autori: MUDr. Jiří Horažďovský, Ph.D

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Nemáte účet?  Registrujte sa

Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa